Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor: repeat observation in cases and controls in New York
- PMID: 22757671
- PMCID: PMC3412610
- DOI: 10.1080/15287394.2012.688485
Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor: repeat observation in cases and controls in New York
Abstract
Essential tremor (ET) is a widespread late-life neurological disease. Genetic and environmental factors are likely to play important etiological roles. Harmane (1-methyl-9H-pyrido[3,4-b]indole) is a potent tremor-producing neurotoxin. Previously, elevated blood harmane concentrations were demonstrated in ET cases compared to controls, but these observations have all been cross-sectional, assessing each subject at only one time point. Thus, no one has ever repeat-assayed blood harmane in the same subjects twice. Whether the observed case-control difference persists at a second time point, years later, is unknown. The current goal was to reassess a sample of our ET cases and controls to determine whether blood harmane concentration remained elevated in ET at a second time point. Blood harmane concentrations were quantified by a well-established high-performance liquid chromatography method in 63 ET cases and 70 controls. A mean of approximately 6 yr elapsed between the initial and this subsequent blood harmane determination. The mean log blood harmane concentration was significantly higher in cases than controls (0.30 ± 0.61 g(-10)/ml versus 0.08 ± 0.55 g(-10)/ml), and the median value in cases was double that of controls: 0.22 g(-10)/ml versus 0.11 g(-10)/ml. The log blood harmane concentration was highest in cases with a family history of ET. Blood harmane concentration was elevated in ET cases compared to controls when reassessed at a second time point several years later, indicating what seems to be a stable association between this environmental toxin and ET.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures


Similar articles
-
Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in essential tremor cases in Spain.Neurotoxicology. 2013 Jan;34:264-8. doi: 10.1016/j.neuro.2012.09.004. Epub 2012 Sep 12. Neurotoxicology. 2013. PMID: 22981972 Free PMC article.
-
Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor.Neurotoxicology. 2008 Mar;29(2):294-300. doi: 10.1016/j.neuro.2007.12.001. Epub 2007 Dec 27. Neurotoxicology. 2008. PMID: 18242711 Free PMC article.
-
Blood Harmane (1-Methyl-9H-Pyrido[3,4-b]indole) and Mercury in Essential Tremor: A Population-Based, Environmental Epidemiology Study in the Faroe Islands.Neuroepidemiology. 2020;54(3):272-280. doi: 10.1159/000505874. Epub 2020 Jan 31. Neuroepidemiology. 2020. PMID: 32007995 Free PMC article.
-
Beta-carboline alkaloids and essential tremor: exploring the environmental determinants of one of the most prevalent neurological diseases.ScientificWorldJournal. 2010 Sep 1;10:1783-94. doi: 10.1100/tsw.2010.159. ScientificWorldJournal. 2010. PMID: 20842322 Free PMC article. Review.
-
Environmental epidemiology of essential tremor.Neuroepidemiology. 2008;31(3):139-49. doi: 10.1159/000151523. Epub 2008 Aug 21. Neuroepidemiology. 2008. PMID: 18716411 Free PMC article. Review.
Cited by
-
Agnosia for head tremor in essential tremor: prevalence and clinical correlates.J Clin Mov Disord. 2016 Feb 12;3:4. doi: 10.1186/s40734-016-0032-0. eCollection 2016. J Clin Mov Disord. 2016. PMID: 26877883 Free PMC article.
-
Heme Oxygenase 1 and 2 Common Genetic Variants and Risk for Essential Tremor.Medicine (Baltimore). 2015 Jun;94(24):e968. doi: 10.1097/MD.0000000000000968. Medicine (Baltimore). 2015. PMID: 26091465 Free PMC article.
-
Tandem gait performance in essential tremor patients correlates with cognitive function.Cerebellum Ataxias. 2015 Jan 10;1:19. doi: 10.1186/s40673-014-0019-2. eCollection 2014. Cerebellum Ataxias. 2015. PMID: 26331043 Free PMC article.
-
How important is the inferior olive in essential tremor? An evolving story.Int Rev Neurobiol. 2022;163:129-132. doi: 10.1016/s0074-7742(22)00055-1. Epub 2022 Jun 21. Int Rev Neurobiol. 2022. PMID: 36172066 Free PMC article. No abstract available.
-
Genomic Markers for Essential Tremor.Pharmaceuticals (Basel). 2021 May 27;14(6):516. doi: 10.3390/ph14060516. Pharmaceuticals (Basel). 2021. PMID: 34072005 Free PMC article. Review.
References
-
- Anderson NJ, Tyacke RJ, Husbands SM, Nutt DJ, Hudson AL, Robinson ES. In vitro and ex vivo distribution of [3H]harmane, an endogenous beta-carboline, in rat brain. Neuropharmacology. 2006;50:269–276. - PubMed
-
- Baldereschi M, Inzitari M, Vanni P, Di Carlo A, Inzitari D. Pesticide exposure might be a strong risk factor for Parkinson's disease. Ann Neurol. 2008;63:128. - PubMed
-
- Benito-Leon J, Bermejo-Pareja F, Morales JM, Vega S, Molina JA. Prevalence of essential tremor in three elderly populations of central Spain. Mov Disord. 2003;18:389–394. - PubMed
-
- Benito-Leon J, Louis ED, Bermejo-Pareja F. Population-based case-control study of cognitive function in essential tremor. Neurology. 2006;66:69–74. - PubMed
-
- Cross AJ, Misra A, Sandilands A, Taylor MJ, Green AR. Effect of chlormethiazole, dizocilpine and pentobarbital on harmaline-induced increase of cerebellar cyclic GMP and tremor. Psychopharmacology (Berl) 1993;111:96–98. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources